. 2022 Nov 8;99(19):e2102–e2113. doi: 10.1212/WNL.0000000000201043
Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.
This is an open access article distributed under the terms of the Creative Commons Attribution License 4.0 (CC BY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Table 3.
Potential Eligibility for Anti-Aβ Treatment
